fr

NOW IN CANADA: HLS Therapeutics Inc. is pleased to announce that Vascepa® (icosapent ethyl [IPE]) is now authorized for sale by Health Canada

If you would like more information about Vascepa®, please fill out the form below.


By clicking here, I agree to allow HLS Therapeutics Inc. to contact me by email regarding its products, programs, news and events. I may update my information, or modify or withdraw my consent, at any time, by contacting HLS Therapeutics Inc.'s Privacy Officer (647-495-9000) at 10 Carlson Court, Suite 410, Etobicoke, Ontario, M9W 6L2, E-mail: privacy@hlstherapeutics.com.

* Required field